We believe that even complex biochemical analyses can be brought from the central laboratory to the point-of-need. As simple as a lateral flow strip, but much more powerful.
Due to the high level of integration, BiFlow's microfluidic cartridges are capable of being driven by a mobile phone. Despite of current regulatory hurdles, we believe that "mobile testing" will become more prevalent and "normal" in the future.
BiFlow's technology platform paves the way towards mobile-phone based diagnostics and other biochemical analyses.
While during Corona pandemic everybody got used to self-testing by antigen lateral flow strips, PCR testing still required a laboratory analysis. BiFlow's technology will allow even such complex molecular diagnostic tests being performed on-site, in short time and by everyone.
With our established technology platform, companies and users can make better decisions faster and more efficiently, thereby strengthening their own market position.
If you want to know how YOU can shape the future with us,
don't hesitate to contact us.